Surgery To Scrap Those SpecsKate Murphy
When noises roused Catherine Schmeltz in the middle of the night, she used to fumble for her glasses before checking on her kids. So when the 41-year-old Kansas City oncology nurse heard about a clinical trial for corneal implants to correct mild nearsightedness, she signed up. Today, her vision is 20/12.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Smartphones Are Killing Americans, But Nobody’s Counting
- Why a Pub in the Middle of Nowhere Was Named the World’s Best Restaurant
- Gulf Coast Oil Spill May Be Largest Since 2010 BP Disaster
- Racist Outburst Prompts Faber’s Exit From Three Company Boards
- Airbus Snaps Up Bombardier Jet in New Challenge to Boeing